For many women, the path to pregnancy is longer and more complicated than expected. One of the most common and least discussed causes of infertility is diminished ovarian reserve, a condition in which the number of viable eggs remaining in the ovaries falls below what is typical for a woman's age. Understanding this condition, recognizing its signs, and knowing what treatment options are available are essential first steps for anyone who has received this diagnosis.

Diminished ovarian reserve does not mean infertility is inevitable. Many women with this diagnosis go on to achieve pregnancy with the right clinical support and a protocol tailored specifically to their biology. The team at Hanabusa IVF, a fertility clinic in San Diego built around treating patients with low ovarian reserve, uses Mini IVF and low-stimulation protocols designed specifically for women who do not respond well to conventional high-dose ovarian stimulation.

This guide covers what diminished ovarian reserve is, how it is diagnosed, what symptoms to watch for, and the full range of treatment strategies currently available to patients.

What Is Diminished Ovarian Reserve?

The ovaries are born with all the eggs a woman will ever have. That pool of eggs, known as the ovarian reserve, gradually diminishes over time through a process that accelerates in the mid-30s and continues until menopause. Diminished ovarian reserve refers to a condition in which this pool depletes earlier or more rapidly than expected, resulting in fewer remaining eggs than is typical for a woman of that age.

This condition is distinct from premature ovarian insufficiency, which involves a near-complete cessation of ovarian function, though both sit on a spectrum of reduced ovarian function. Diminished ovarian reserve is typically defined through specific hormonal markers and confirmed through blood tests and ultrasound imaging.

Common Causes

Age-Related Decline

Age is the most significant factor in ovarian reserve depletion. All women experience a natural decline over time, but this process accelerates after the mid-30s. By 40, most women have markedly fewer eggs than they did a decade earlier, and egg quality also diminishes with age. While age-related decline is universal, the rate varies significantly from person to person.

Genetic and Hereditary Factors

Some women are born with a smaller ovarian reserve or carry genetic variants that cause their reserve to deplete more quickly than average. Fragile X premutation carriers face elevated risk of early ovarian aging. A family history of early menopause is also associated with an increased likelihood of diminished ovarian reserve in younger relatives.

Prior Ovarian Surgery

Surgeries involving the ovaries, including removal of cysts, endometriomas, or ovarian tissue for other reasons, can remove healthy follicular tissue along with the pathology being treated. Repeated surgeries or operations on ovaries with limited reserve carry the highest risk of further reducing egg supply. Women with a history of ovarian surgery should discuss this history with their fertility specialist early in the evaluation process.

Prior Cancer Treatment

Chemotherapy and radiation therapy, particularly pelvic radiation, are well-recognized causes of reduced ovarian function. The extent of damage depends on the type of chemotherapy agent, the total dose, and whether the ovaries were in the radiation field. Women who underwent cancer treatment at a young age may have significantly reduced reserve even if they appear healthy.

Autoimmune Conditions

Certain autoimmune conditions can cause the immune system to target ovarian tissue, accelerating follicle depletion. Thyroid autoimmunity and other systemic autoimmune disorders have been associated with premature ovarian aging in a subset of patients.

Unexplained Cases

A substantial number of women with diminished ovarian reserve have no identifiable risk factors. Some women in their mid-20s and early 30s present with low ovarian reserve for reasons that remain idiopathic despite thorough investigation.

Diagnosis: Key Tests and What They Mean

AMH (Anti-Mullerian Hormone)

AMH is produced by small follicles in the ovary and serves as a reliable proxy for the remaining egg pool. Low AMH levels indicate reduced ovarian reserve. AMH can be measured at any point in the menstrual cycle, making it a convenient first-line test when low reserve is suspected.

FSH and Day 3 Testing

Follicle-stimulating hormone is released by the pituitary gland to drive ovarian follicle development. When fewer follicles are present, the pituitary compensates by releasing more FSH. Elevated FSH on day 2 or 3 of the cycle is a classic indicator of diminished ovarian reserve. It is typically measured alongside estradiol, which can mask elevated FSH if it is unusually high early in the cycle.

Antral Follicle Count

An antral follicle count is performed via transvaginal ultrasound at the start of a cycle. It counts the small resting follicles visible in both ovaries. A low antral follicle count corresponds with lower ovarian reserve and predicts a reduced response to stimulation medications. Many clinicians consider the antral follicle count one of the most informative markers available.

Symptoms to Watch For

Diminished ovarian reserve frequently presents without obvious symptoms, which is part of why it goes undetected until a woman is actively trying to conceive. That said, some women notice signs that warrant earlier investigation.

Shorter menstrual cycles are one of the earliest recognizable indicators. As follicular development accelerates to compensate for a depleted pool, cycles that previously ran 28 to 30 days may shorten to 24 or 25 days. Some women also report lighter menstrual flow over time.

Difficulty conceiving after several months of regular unprotected intercourse, especially in women under 35, warrants evaluation. For women over 35, evaluation is recommended after six months of trying without success. Any woman with known risk factors for diminished ovarian reserve should consider proactive evaluation before attempting to conceive.

A history of poor response to stimulation in a prior IVF cycle is a strong signal. If a previous cycle yielded fewer than three or four eggs despite standard doses, diminished ovarian reserve is likely, even if initial bloodwork appeared within normal range.

Treatment Strategies

Mini IVF and Low-Stimulation Protocols

For women with diminished ovarian reserve, conventional high-dose IVF stimulation often yields disappointing results. Rather than pushing harder for more eggs, Mini IVF uses lower doses of oral medications or minimal injectables to retrieve the few eggs that are available. This approach prioritizes egg quality, reduces cycle cancellation rates, and significantly lowers the physical burden on the patient. For many DOR patients, this shift in philosophy produces better outcomes than escalating doses ever did.

Natural Cycle IVF

Natural cycle IVF involves retrieving the single egg the body selects in a given month without any stimulation. Per-cycle success rates are lower than stimulated cycles, but for women who do not respond to any stimulation, it offers a path to IVF with their own eggs.

Ovarian Rejuvenation with PRP

Platelet-rich plasma (PRP) ovarian rejuvenation is an emerging investigational approach in which growth factors from the patient's own blood are introduced into ovarian tissue to stimulate dormant follicles. While still being studied and not yet considered standard of care, some patients with severely diminished reserve have seen encouraging early results when this procedure is combined with personalized Mini IVF protocols.

Donor Egg IVF

When ovarian reserve is too low to yield viable eggs even with optimized protocols, donor egg IVF offers a highly effective alternative. Using eggs from a younger, screened donor allows women to carry a pregnancy and experience childbirth. Many women who pursue donor eggs report that the experience of pregnancy and birth is deeply meaningful, regardless of the genetic path that made it possible.

Finding the Right Specialist

The standard IVF model, built around aggressive stimulation and high retrieval numbers, does not serve women with diminished ovarian reserve well. This patient population requires a clinic that actively specializes in low-stimulation approaches and has specific experience managing DOR. When evaluating a clinic, ask what percentage of their patients have DOR or low AMH, what protocols they use for poor responders, and what their outcomes data shows for this group specifically.

Conclusion

Diminished ovarian reserve is a challenging diagnosis, but it is not the end of the fertility road for most women. With a correctly matched clinical protocol and realistic expectations about the process, many patients do achieve the pregnancy they are working toward. The critical variable is finding a team whose approach is built around the individual patient rather than a generalized model designed for the average case.

For women seeking specialized care for diminished ovarian reserve, low AMH, or prior IVF failure, Hanabusa IVF in San Diego offers personalized Mini IVF and low-stimulation protocols tailored to each patient's unique ovarian profile. Consultations are available for patients at all stages of their fertility journey, including those who have been told their options are limited elsewhere.